Pius Okong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Pius Okong has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Metin Gulmezoglu
UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Reproductive Health and Research, World Health Organization, Geneva 27, Switzerland
1 shared publication Albert Profy
Indevus Pharmaceuticals, Inc, Lexington, Massachusetts, USA
1 shared publicationAnatoli Kamali
MRC Uganda/UVRI Research Unit on AIDS, Entebbe, Uganda
1 shared publication- Andrew J. Nunn
Medical Research Council Clinical Trials Unit at UCL
1 shared publication - Anna Bergström
SWEDESD, Department of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden
1 shared publication A‐B Ransjö‐Arvidson
Department of Women's and Children's Health, Karolinska Institutet, SE‐171 77 Stockholm, Sweden
1 shared publication
Latest Publications
- Open Access
- 5 May 2010
- Published by BMJ in Sexually Transmitted Infections
- Vol. 86 (3) , 222-226
A randomised placebo-controlled safety and acceptability trial of PRO 2000 vaginal microbicide gel in sexually active women in Uganda
Objectives To determine the safety of 0.5% and 2% PRO 2000 gel in terms of local and systemic adverse events (AE) and the acceptability of gel use. Design A randomised placebo-controlled trial among healthy, sexually active African women aged 18–45 years. Between June 2003 and September 2004, 180 consenting women were randomly assigned to one of four groups: PRO 2000 gel (0.5% or 2%), placebo gel, or condom use only. Participants were screened for sexually transmitted infections, with HIV counselling and testing. Women randomly assigned to gel used this intravaginally twice a day for 28 days. Follow-up visits were fortnightly up to 6 weeks from enrolment, and comprised a physical examination including colposcopy, laboratory testing and questionnaire interviews. Results Ten women were lost to follow-up, none due to AE. Adherence with total gel doses was 69%. Observed rates of the primary toxicity endpoints, ulceration greater than 2×1 cm and clinically relevant coagulation abnormalities were, for PRO 2000 0.5%: 1.6% (95% CI 0.04% to 8.5%) and 0% (97.5% CI 0% to 5.7%), and for PRO 2000 2%: 0% and 0% (97.5% CI 0% to 5.9%). Women randomly assigned to active gels did not show an increased rate of AE. Gel use had no significant effect on haematology and biochemistry results. Women found gel use highly acceptable. Conclusions Both concentrations of PRO 2000 gel were found to be safe and well tolerated. These data justified testing the gels in large-scale effectiveness trials.
- 5 May 2010
- Published by BMJ in Sexually Transmitted Infections
- Vol. 86 (3) , 222-226
Open AccessA randomised placebo-controlled safety and acceptability trial of PRO 2000 vaginal microbicide gel in sexually active women in Uganda
Objectives To determine the safety of 0.5% and 2% PRO 2000 gel in terms of local and systemic adverse events (AE) and the acceptability of gel use. Design A randomised placebo-controlled trial among healthy, sexually active African women aged 18–45 years. Between June 2003 and September 2004, 180 consenting women were randomly assigned to one of four groups: PRO 2000 gel (0.5% or 2%), placebo gel, or condom use only. Participants were screened for sexually transmitted infections, with HIV counselling and testing. Women randomly assigned to gel used this intravaginally twice a day for 28 days. Follow-up visits were fortnightly up to 6 weeks from enrolment, and comprised a physical examination including colposcopy, laboratory testing and questionnaire interviews. Results Ten women were lost to follow-up, none due to AE. Adherence with total gel doses was 69%. Observed rates of the primary toxicity endpoints, ulceration greater than 2×1 cm and clinically relevant coagulation abnormalities were, for PRO 2000 0.5%: 1.6% (95% CI 0.04% to 8.5%) and 0% (97.5% CI 0% to 5.7%), and for PRO 2000 2%: 0% and 0% (97.5% CI 0% to 5.9%). Women randomly assigned to active gels did not show an increased rate of AE. Gel use had no significant effect on haematology and biochemistry results. Women found gel use highly acceptable. Conclusions Both concentrations of PRO 2000 gel were found to be safe and well tolerated. These data justified testing the gels in large-scale effectiveness trials.
- Open Access
- 21 January 2009
- Published by Springer Nature in Reproductive Health
- Vol. 6 (1) , 2
Active management of the third stage of labour without controlled cord traction: a randomized non-inferiority controlled trial
The third stage of labour refers to the period between birth of the baby and complete expulsion of the placenta. Some degree of blood loss occurs after the birth of the baby due to separation of the placenta. This period is a risky period because uterus may not contract well after birth and heavy blood loss can endanger the life of the mother. Active management of the third stage of labour (AMTSL) reduces the occurrence of severe postpartum haemorrhage by approximately 60–70%. Active management consists of several interventions packaged together and the relative contribution of each of the components is unknown. Controlled cord traction is one of those components that require training in manual skill for it to be performed appropriately. If it is possible to dispense with controlled cord traction without losing efficacy it would have major implications for effective management of the third stage of labour at peripheral levels of health care.
- 21 January 2009
- Published by Springer Nature in Reproductive Health
- Vol. 6 (1) , 2
Open AccessActive management of the third stage of labour without controlled cord traction: a randomized non-inferiority controlled trial
The third stage of labour refers to the period between birth of the baby and complete expulsion of the placenta. Some degree of blood loss occurs after the birth of the baby due to separation of the placenta. This period is a risky period because uterus may not contract well after birth and heavy blood loss can endanger the life of the mother. Active management of the third stage of labour (AMTSL) reduces the occurrence of severe postpartum haemorrhage by approximately 60–70%. Active management consists of several interventions packaged together and the relative contribution of each of the components is unknown. Controlled cord traction is one of those components that require training in manual skill for it to be performed appropriately. If it is possible to dispense with controlled cord traction without losing efficacy it would have major implications for effective management of the third stage of labour at peripheral levels of health care.
- 24 April 2007
- Published by Wiley in Acta Paediatrica
- Vol. 96 (5) , 655-658
Immediate maternal thermal response to skin‐to‐skin care of newborn
Aim: To elucidate the immediate maternal thermal skin response when placing the neonate on the mothers' chest, skin‐to‐skin (STS).Methods: Ugandan mothers with non‐asphyxiated newborns after vaginal delivery (n = 39) were studied. Maternal skin and axillary temperatures were measured immediately before STS contact, then every 2 min for 20 min and finally 10 min after removing the neonate. Neonatal axillary/forehead temperatures were measured immediately before STS contact, and twice after initiating STS, followed by a measurement 10 min after the newborn had been removed.Results: A rapid thermal response was demonstrated in maternal breast skin immediately after STS contact. It rose by 0.5°C (p < 0.0001) on average the first 2 min after STS contact and fell by 0.5°C 10 min after we had removed the neonate (p < 0.0001). Maternal axillary temperature also rose 2 min after initiation of STS (p < 0.0001) but stayed constant 10 min after removal of the newborn from the STS position.Conclusion: The findings indicate that there is a rapid maternal, thermal response to the positioning of the newborn STS. The tactile contact may elicit a maternal adaptation enhancing the warming of the newborn. Possible mechanisms include maternal autonomic nerve‐mediated skin vasodilatation.
- 24 April 2007
- Published by Wiley in Acta Paediatrica
- Vol. 96 (5) , 655-658
Immediate maternal thermal response to skin‐to‐skin care of newborn
Aim: To elucidate the immediate maternal thermal skin response when placing the neonate on the mothers' chest, skin‐to‐skin (STS).Methods: Ugandan mothers with non‐asphyxiated newborns after vaginal delivery (n = 39) were studied. Maternal skin and axillary temperatures were measured immediately before STS contact, then every 2 min for 20 min and finally 10 min after removing the neonate. Neonatal axillary/forehead temperatures were measured immediately before STS contact, and twice after initiating STS, followed by a measurement 10 min after the newborn had been removed.Results: A rapid thermal response was demonstrated in maternal breast skin immediately after STS contact. It rose by 0.5°C (p < 0.0001) on average the first 2 min after STS contact and fell by 0.5°C 10 min after we had removed the neonate (p < 0.0001). Maternal axillary temperature also rose 2 min after initiation of STS (p < 0.0001) but stayed constant 10 min after removal of the newborn from the STS position.Conclusion: The findings indicate that there is a rapid maternal, thermal response to the positioning of the newborn STS. The tactile contact may elicit a maternal adaptation enhancing the warming of the newborn. Possible mechanisms include maternal autonomic nerve‐mediated skin vasodilatation.